Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence Imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity
Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence Imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity
复制标题
DOI:
10.1021/la0607499
复制
发表时间:
2006-09-12
期刊:
影响因子:
3.9
通讯作者:
Lal, Ratnesh
中科院分区:
文献类型:
--
作者:
Ramachandran, Srinivasan;Quist, Arjan P.;Lal, Ratnesh
Cisplatin is the most effective cytotoxic agent against many cancers. Its usage, however, is limited due to inefficient uptake by the target cells. A liposomal formulation of cisplatin is reported to partly overcome this limitation. Physicochemical characteristics of the liposome-cisplatin preparation, including its size, stability, encapsulation efficiency, and cytoplasmic internalization efficiency, play a significant role in an effective usage of liposomal formulations. We have used atomic force microscopy (AFM) to determine physicochemical characteristics of cisplatin-encapsulated liposomes, AFM and fluorescence microscopy to examine their cytoplasmic internalization, and Live/ Dead assay to examine their cell toxicity. Nonencapsulated cisplatin is globular and 10-50 nm in size. AFM force-dissection and stiffness measurements show that cisplatin-encapsulated liposomes are significantly stiffer (similar to 100%) and more stable than liposomes without encapsulated cisplatin. Cisplatin-encapsulated liposomes of similar to 250 nm diameter (nanoliposomes) are most efficiently internalized and induce cell toxicity in a time-dependent manner. Liposomes without cisplatin of similar dimensions, although internalized in the cell cytoplasm, do not induce cell toxicity.